To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Timing of bisphosphonate administration does not affect fracture healing or complications

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2013

Timing of bisphosphonate administration does not affect fracture healing or complications

Vol: 2| Issue: 7| Number:256| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?

J Bone Joint Surg Br. 2012 Jul;94(7):956-60

Contributing Authors:
TY Kim YC Ha BJ Kang YK Lee KH Koo

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

90 osteoporotic patients, that have undergone fixation for an intertrochanteric fracture, were randomized to receive oral administration of a bisphosphonate (Risedronate) starting either one week, one month, or three months after surgery. The results demonstrate that the timing of bisphosphonate administration following hip fracture surgery does not affect time to fracture healing or incidence of ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.